PMID: 42394899

PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo.

Peng Haisheng, Chai Yanqun, Gong Chen, Hao Yue, Peng Yanbo, Zhang Wenyuan, Liu Xiaoying, Tang Shukun, Kong Qingfei, Wang Qun

Bioengineering & translational medicine · 2026

Vol. 11, Issue 4, pp. e70144

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.